Table 1 Baseline characteristics of the participants
Participants with CHD outcome (n = 57) | Participants without CHD outcome (n = 2223) | P value | Whole study population (n = 2280) | |
|---|---|---|---|---|
Age (y) | 59.2 ± 9.7 | 37.6 ± 13.1 | 0.001 | 38.2 ± 13.4 |
Male (%) | 59.6 | 42.3 | 0.007 | 42.8 |
Smoking (%) | 22.8 | 11.5 | 0.003 | 11.7 |
Body mass index (m 2 /kg) | 28.4 ± 4.4 | 26.5 ± 4.8 | 0.004 | 26.5 ± 4.8 |
Waist circumference (cm) | 97.2 ± 10.1 | 87.8 ± 13.3 | 0.001 | 88.0 ± 13.4 |
Serum creatinine (μmol/L) | 99.5 ± 16.7 | 91.7 ± 13.5 | 0.001 | 91.9 ± 13.7 |
eGFR (ml/min/1.73 m2) | 78.7 ± 13.0 | 79.8 ± 16.1 | 0.61 | 79.8 ± 16.1 |
Systolic blood pressure (mm Hg) | 130 ± 17.4 | 109 ± 14.9 | 0.001 | 110 ± 15.3 |
Diastolic blood pressure (mm Hg) | 80.0 ± 10.6 | 72.4 ± 10.3 | 0.001 | 72.6 ± 10.3 |
Fasting blood glucose (mg/dL) | 106 ± 39.9 | 88.0 ± 16.6 | 0.001 | 88.9 ± 17.7 |
Total cholesterol (mg/dL) | 216 ± 38.0 | 182 ± 36.8 | 0.001 | 183 ± 37.3 |
Serum triglycerides (mg/dL) | 190 ± 107 | 132 ± 77.0 | 0.001 | 133 ± 79.0 |
LDL-C (mg/dL) | 140 ± 31.2 | 112 ± 31.4 | 0.001 | 113 ± 31.6 |
HDL-C (mg/dL) | 40.2 ± 8.0 | 43.3 ± 10.4 | 0.025 | 43.2 ± 10.4 |
TG/HDL-ratio | 5.0 ± 3.1 | 3.4 ± 2.6 | 0.001 | 3.5 ± 2.6 |
Diabetes (%) | 14.3 | 3.9 | 0.003 | 4.2 |
Hypertension (%) | 43.9 | 8.2 | 0.001 | 9.1 |
Chronic kidney disease (%) | 4.4 | 6.7 | 0.41 | 6.7 |